Luteal phase support with GnRH agonist after egg retrieval trigger
Part of Women’s health & pregnancy clinical trials.
This trial tests whether giving a medication called a GnRH agonist during the luteal phase (the time after egg retrieval) can help with IVF success. It is for people who are using a specific medication protocol (recombinant FSH with an antagonist) and have certain hormone levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 39 years old.
- This is your first or second time trying IVF or ICSI.
- Your body mass index (BMI) is under 35.
- Your anti-Müllerian hormone (AMH) level is between 1 and 5 ng/mL, or your antral follicle count is between 8 and 39 (based on tests within the last year).
- You are using a specific type of medication (recombinant FSH) and following an antagonist protocol.
- You do not have HIV, need sperm from a testicular biopsy, or plan to use preimplantation genetic diagnosis (PGD).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a hormone called GnRH can improve success rates during IVF (in vitro fertilization) by supporting the embryo after transfer. If you're having IVF for the first to third time and your doctor is considering different support methods, this trial may explore options for you.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
This trial tests whether a hormone called GnRH can help support the lining of the uterus after IVF, ICSI, or frozen embryo (FET) embryo transfer. It may be offered around the time of embryo transfer to improve the chances of a successful implantation.
This trial tests whether giving a medication called a GnRH agonist (which affects hormones) before a frozen embryo transfer can improve the chances of pregnancy in women with infertility. It aims to see if this treatment helps the uterus accept the embryo better.
This study tests different medication approaches to help women who had a low number of eggs in a previous IVF cycle produce more eggs this time. The goal is to find a better stimulation method for women with this 'low response' pattern.
This trial tests whether giving extra luteinizing hormone (LH) can improve embryo quality in women with very low LH levels during IVF. It may help you if you have low LH and are using a specific type of fertility medication.
Hear when a new In Vitro Fertilization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.